A clinical research study of an investigational drug for RRMS that is taken by mouth.
Right now, doctors who specialize in the treatment of multiple sclerosis are conducting FREEDOMS II: a clinical research study of an investigational drug for MS that is taken by mouth, rather than injected.
If you have relapsing-remitting multiple sclerosis (RRMS), you may be able to participate in the FREEDOMS II study.
The investigational drug may provide treatment for MS:
- Without some of the side effects that are often associated with currently available treatments for MS — such as flu-like symptoms.
- Without the need for injections (the investigational drug is taken once daily by mouth).
Everyone who participates in the FREEDOMS II study will receive the following (at no cost):
- Study-related care and monitoring from a physician and healthcare professionals who understand how multiple sclerosis can affect your life.
- Study drug — the investigational drug and/or a placebo (a substance designed to have no effect on health). The investigational drug is taken by mouth. Everyone who participates in this study has the same 2 in 3 chance of receiving the investigational drug.
To learn more about this clinical research study, please take a moment to read this Web site.
To find out if you may be able to participate: